Humana (HUM) shares are down about 4% to $215.30 in morning trading after Bloomberg reported that the company lost its lawsuit seeking to reverse cuts to its Medicare bonus payments. A Texas district court ruled in favor of the government’s motion to dismiss the case, affirming the Medicare program’s downgrade of Humana’s quality ratings and dealing a blow for the insurer, which hoped the court would restore billions in revenue, according to Bloomberg’s report.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HUM:
- Humana loses in suit to reverse Medicare bonus payment cut, Bloomberg reports
- ACA marketplace plans seek double digit rate increases for 2026, WSJ says
- U.S. Health insurers prescription drug denials on the rise, NYT says
- Humana price target lowered to $260 from $280 at Truist
- Trump Trade: U.S. slaps 30% tariff rate on EU, Mexico